Alkermes
Leadership moves, last update 2 months ago
Pharma biotech · Headquarters Dublin, Ireland
Everything we hold on Alkermes, newest first. Every line links to the filing or report it came from.
- 2026-06-26Headcount Not Stated Leadership moves
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
Alkermes, a brain-disease drugmaker, is installing a new CEO to push into the orexin market against Lilly and Takeda, a strategic pivot reported without headcount detail. The announcement names an executive change, not hiring plans.
- 2026-05-20Pay Change Leadership moves
Alkermes plc. 8-K filing (Item 5.02): officer or director change
Alkermes plc has amended its stock option and incentive plan, increasing share authorization for issuance, a move that could affect compensation for employees in Ireland.
- 2026-02-25Headcount Not Stated Leadership moves
Alkermes plc. 8-K filing (Item 5.02): officer or director change
Alkermes plc's CEO retires in Dublin; the executive team will transition leadership by year-end.
- 2025-12-31Pay Change Pay and benefits
ALKERMES PLC: $7,915,081 total compensation for the principal executive officer, fiscal year ended 2025-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2024-12-31Pay Change Pay and benefits
ALKERMES PLC: $10,131,193 total compensation for the principal executive officer, fiscal year ended 2024-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2023-12-31Pay Change Pay and benefits
ALKERMES PLC: $9,442,066 total compensation for the principal executive officer, fiscal year ended 2023-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2022-12-31Pay Change Pay and benefits
ALKERMES PLC: $10,314,172 total compensation for the principal executive officer, fiscal year ended 2022-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker